has not been reached. [7] However, in recent years, insulin resistance (IR) has been reported to play an important role in the progression of PCOS. [8] [9] [10] PCOS may present with metabolic abnormalities such as IR and visceral obesity at a young age. Long-term exposure to these abnormalities during fertile life may increase the reverse impacts and expose these women to higher risks of metabolic syndrome (MetS), cardiovascular diseases and type II diabetes mellitus. [11] While melatonin (N-acetyl-5-methoxytryptamine), a neurohormone synthesized from the aromatic amino acid tryptophan mainly by the pineal gland of humans. [12] The important of melatonin in human reproduction is still unidentified. A numerous study suggests that melatonin and reproductive hormones are closely related. [13] This concept is based on observation of influence melatonin on sex steroid production at different stages of ovarian follicular maturation as melatonin receptors have been demonstrated at multiple sites in ovary and in intrafollicular fluid. In addition, several studies found that increased melatonin concentration in serum of women with PCOS, and also indicating a feedback mechanism due to reduced melatonin concentration at the level of ovarian follicles. This could interpretation role of melatonin in the pathogenesis of PCOS. [14] This study aimed to evaluate the role of melatonin in women with PCOS and its correlation with insulin, IR, and glycated hemoglobin (HbA1c).
MaterIals and Methods

Study design
A prospective cross-sectional study was designed taking 60 PCOS patients and 30 controls women whose ages were between 15 and 35 years old, from the beginning of January 2019 to the ending of April 2019. These patients admitted to obstetrics and gynecology unit at Babylon Teaching Hospital. An interview was carried out with these patients using questionnaire form designed by the investigator, including their demographic characteristics, age, weight, length, body mass index… etc.
Inclusion criteria for selection of cases women
These studies depend on the Rotterdam European Society for Human Reproduction, and Embryology/American Society for Reproductive Medicine these criteria were used to diagnose PCOS and women with presence of any two of the following three features were included in the study: 
Inclusion criteria for selection of controls women
Exclusion criteria
All patients with metabolic or endocrinology disorders, including thyroid disorder, diabetes mellitus, hypertension, Cushing's syndrome, acromegaly, premature ovarian failure, virilizing adrenal or ovarian tumors, and history of using contraceptive through the past 6 months were excluded from this study.
Sampling
Five milliliter of the blood sample was taken on day 2 of the menstrual cycle by vein puncture from each subject enrolled in this study. Blood samples were collected between 07:00 a.m. and 08:00 a.m., and placed into sterile test tubes, after blood clotting, centrifuged at 2500 RPM for 15 min then clot removed and remain re-centrifuged at 2500 RPM for 10 min and the obtained serum were aspirated using mechanical micropipette and transferred into clean test tubes which labeled and stored in deep freeze at − 20°C for serum melatonin, insulin, IR, and HbA1c measurement.
Statistical analysis
Computerized statistically analysis was performed using SPSS statistical program version 24 (SPSS, IBM Company, Chicago, USA). Comparison was carried out using; Chi-square and t-test probability (P value).
Ethical consideration
The study was conducted in accordance with the ethical principles that have their origin in the Declaration of Helsinki.
It was carried out with a patient s verbal and analytical approval before the sample was taken. The study protocol and the subject information and consent form were reviewed and approved by a local ethics committee.
results
Comparison of age in polycystic ovarian syndrome and control women
A total of 60 PCOS women and 30 non-PCOS women (control group) were examined for (melatonin, insulin, IR, and HbA1c). Their age range group was between 15 and 35 years [ Table 1 ].
The study showed that there is the significant difference between PCOS women and the control group concerning melatonin level, and the highest mean of melatonin was occurred in PCOS women (61.21 ± 13.78 vs. 28.61 ± 6.73) [ Table 2 ].
The correlation between melatonin and HbA1c was positive in PCOS women in this study. Higher Mean values of HbA1c were Figure 1 and Table 3 ].
Positive correlation between insulin and melatonin was observed in PCOS women involved in this study, and higher mean of insulin was shown in PCOS women when compared with control group (18.99 ± 3.75 vs. 8.23 ± 1.88) with significant relation between them [ Figure 2 and Table 4 ].
Positive correlation between melatonin and IR levels was observed in PCOS women included in this study, and higher mean of IR was recorded in PCOS women when compared with control group (4.70 ± 1.09 vs. 1.54 ± 0.44) with significant relation [ Figure 3 and Table 5 ].
dIscussIon
This study found that there was no significant difference between PCOS women and control group concerning age (24.25 ± 5.12 vs. 23.63 ± 4.06) [ Table 1 ]. This agreement [15] study, that found PCOS affects women of childbearing age without higher prevalence by ethnic groups, but the signs and symptoms may differ by ethnicity, and disagreed with [16] who reported that PCOS varies with age but continues to be more common among women aged <35 years than in those above 35 years, this finding could be attributed to that the women in that age are physiological active concerning the fertility and ovulation.
The study also showed that there is the significant difference between PCOS women and the control group concerning melatonin level, and the highest mean of melatonin was occurred in PCOS women compared with control group (61.21 ± 13.78 vs. 28.61 ± 6.73), [ Table 2 ].
Melatonin is normally synthesized in the ovary, as both melatonin synthesizing enzymes arylalkylamine N-acetyltransferase and hydroxyindole-O-methyltransferase are present in ovarian tissue. [17] The study by Tenorio et al. [18] found that the presence of melatonin receptors in the follicular cells of rats and mice, suggests possible melatonin production in the ovary. Its well-documented role as an antioxidant may be associated with follicular development and oocyte quality, interfering in processes such as oocyte maturation and ovulation. [19] This study agreement with, [20] Experimental studies with female rats and hamsters reported that removal of the pineal gland leads to a decrease in melatonin levels with consequent premature vaginal opening, ovarian hypertrophy, increased cornification of vaginal cells and chronic anovulation, effect that can be reversed after the administration of melatonin. [21] The reduction of melatonin ovary can decrease embryo implantation, as well as interfere with pregnancy when rats are subjected to short photoperiods, showing an increase in melatonin levels accompanied by depressions in follicle-stimulating hormone and reduction in follicle development, becoming anestrous, [18] and also with Woo et al.'s [22] study, found the expression of receptors for melatonin MT1 and MT2 has been identified in human reproductive tissues, including the mammary epithelium, myometrium, ovary, and granulosa-luteal cells. In females, the influence of melatonin on the reproductive function can be inferred from studies that indicate that high levels of melatonin cause amenorrhea, [23] disturbance in gonadotropin secretion, and the secretion of prolactin in response to the photoperiod. [24] Studies have suggested that melatonin has a role in ovarian physiology, given that high concentrations of melatonin have been detected in follicular fluid. [18] IR and compensatory hyperinsulinemia can be triggered by obesity with visceral fat accumulation. Hyperinsulinemia affects granulosa cells in small follicles and theca cells. This condition induces early response to luteinizing hormones on granulosa cells of small follicles and causes premature differentiation of these cells, which eventually results in anovulation. Hyperinsulinemia may adversely affect the endometrial functions and environment, and evoke implantation disturbance. [25] Our study disagreed with [26] study, they found supplementation with 3 mg/day of melatonin after 8 weeks did not influence glucose control and IR in patients with schizophrenia.
These varied results of different studies may be associated with the differences in the type of diseases, dosage of melatonin consumption, and duration of the studies. Increased ovarian androgen production in PCOS includes hyperinsulinemia due to IR and increased volume of theca cells in an expanded ovarian stroma. A negative correlation has been seen with fasting glucose/insulin ratio. This can be explained by diverse mode of action of melatonin, firstly by a direct action at receptors MT1 and MT2 leading to alteration in ovarian steroidogenesis and secondly by its action at follicular level as antioxidant. [27, 28] They showed that melatonin supplementation to patients with PCOS for 12 weeks significantly decreased serum insulin levels, homeostatic model assessment-IR, total-and low-density lipoprotein-cholesterol levels of women with PCOS.
On the basis of existing evidence, melatonin administration may have some beneficial effects on glucose homeostasis and lipid profiles. And also demonstrated that melatonin intake (5 mg/kg) in MetS rats for 6 weeks significantly improved IR and dyslipidemia.
conclusIons
There were significant increases in serum levels of (melatonin, HbA1c, insulin, and IR) in women with PCOS compared to healthy women (control group). In addition, there was a positive correlation of melatonin with insulin, IR, and HbA1c.
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